Modelling acute lung injury: infections versus bacterial components

A. De Vos (Amsterdam, Netherlands)

Source: Annual Congress 2012 - PG4 Experimental models for respiratory medicine: strengths and limitations
Session: PG4 Experimental models for respiratory medicine: strengths and limitations
Session type: Postgraduate Course
Number: 53
Disease area: Respiratory infections

Slide presentationPDF journal article, handout or slidesMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. De Vos (Amsterdam, Netherlands). Modelling acute lung injury: infections versus bacterial components. Annual Congress 2012 - PG4 Experimental models for respiratory medicine: strengths and limitations

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Human acute lung injury versus the endotoxin model
Source: Annual Congress 2008 - Acute lung injury. Do we know what it is? A look at different models
Year: 2008


Interplay between bacterial infections, hypoxia and the development of chronic lung diseases
Source: Annual Congress 2009 - Mechanisms of infection: what's new?
Year: 2009


Difference of immune response in patients with severe acute pneumonia and lung abscesses
Source: Eur Respir J 2004; 24: Suppl. 48, 189s
Year: 2004

Modeling resolution of direct acute lung injury
Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury
Year: 2011

Acute lung injury: how the lung inflammatory response works
Source: Eur Respir J 2003; 22: 22S-23S
Year: 2003


Acute and chronic lung infections
Source: ERS Course 2015
Year: 2015

Mechanisms of acute lung injury
Source: Lung Science Conference 2004 - Application of our knowledge of the basic processes of lung inflammation in lung diseases
Year: 2004


Ventilator-associated lung injury: a search for better therapeutic targets
Source: Eur Respir J 2007; 30: 1216-1226
Year: 2007



Salmeterol prevents pneumonia and reduces biomarkers of inflammation/epithelial damage but not acute lung injury following oesophagectomy-the results of BALTI-prevention trial
Source: Annual Congress 2013 –Acute lung injury: novel clinical and experimental insights
Year: 2013

The zymosan model of acute lung injury and multiple organ failure
Source: Annual Congress 2008 - Acute lung injury. Do we know what it is? A look at different models
Year: 2008


Acute lung injury and ventilator-associated pneumonia: introduction
Source: Eur Respir J 2003; 22: 1S
Year: 2003


Strategies to modify repair in acute and chronic lung injury
Source: Lung Science Conference 2004 - Application of our knowledge of the basic processes of lung inflammation in lung diseases
Year: 2004

Neutralizing the complement component C5a protects against lung injury and extrapulmonary organ injury in pneumococcal pneumonia induced sepsis
Source: International Congress 2014 – Critical illness and therapeutic interventions
Year: 2014

Local immune protection mechanisms during bacterial infection of the airways in patients with interstitial lung diseases
Source: Annual Congress 2009 - Mechanisms of infection: what's new?
Year: 2009

Effect of alveolar type II cells in acute lung injury model
Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury
Year: 2015

Time course of lung parenchyma remodelling in different models of extrapulmonary acute lung injury
Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies
Year: 2008

How to manage pseudomonas infections: chronic and acute
Source: CME Online 2019
Year: 2019

Novel swine model of transfusion-related acute lung injury (TRALI)
Source: Annual Congress 2012 - The many roads to lung injury
Year: 2012